Your browser doesn't support javascript.
loading
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3.
Faber, Jennifer; Berger, Moritz; Wilke, Carlo; Hubener-Schmid, Jeannette; Schaprian, Tamara; Santana, Magda M; Grobe-Einsler, Marcus; Onder, Demet; Koyak, Berkan; Giunti, Paola; Garcia-Moreno, Hector; Gonzalez-Robles, Cristina; Lima, Manuela; Raposo, Mafalda; Melo, Ana Rosa Vieira; de Almeida, Luís Pereira; Silva, Patrick; Pinto, Maria M; van de Warrenburg, Bart P; van Gaalen, Judith; de Vries, Jeroen; Oz, Gulin; Joers, James M; Synofzik, Matthis; Schols, Ludger; Riess, Olaf; Infante, Jon; Manrique, Leire; Timmann, Dagmar; Thieme, Andreas; Jacobi, Heike; Reetz, Kathrin; Dogan, Imis; Onyike, Chiadikaobi; Povazan, Michal; Schmahmann, Jeremy; Ratai, Eva-Maria; Schmid, Matthias; Klockgether, Thomas.
Afiliação
  • Faber J; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Berger M; Department of Neurology, University Hospital Bonn, Bonn, Germany.
  • Wilke C; University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics, and Epidemiology, Bonn, Germany.
  • Hubener-Schmid J; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Schaprian T; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
  • Santana MM; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Grobe-Einsler M; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Onder D; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Koyak B; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Giunti P; Department of Neurology, University Hospital Bonn, Bonn, Germany.
  • Garcia-Moreno H; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Gonzalez-Robles C; Department of Neurology, University Hospital Bonn, Bonn, Germany.
  • Lima M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Raposo M; Department of Neurology, University Hospital Bonn, Bonn, Germany.
  • Melo ARV; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • de Almeida LP; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Silva P; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Pinto MM; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • van de Warrenburg BP; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • van Gaalen J; Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • de Vries J; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal.
  • Oz G; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal.
  • Joers JM; Instituto de Biologia Molecular e Celular (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal.
  • Synofzik M; Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal.
  • Schols L; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Riess O; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Infante J; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Manrique L; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Timmann D; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
  • Thieme A; Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Jacobi H; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Reetz K; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
  • Dogan I; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Onyike C; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Povazan M; Department of Neurology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Schmahmann J; University Medical Center Groningen, Neurology, Groningen, the Netherlands.
  • Ratai EM; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
  • Schmid M; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
  • Klockgether T; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Ann Neurol ; 95(2): 400-406, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37962377
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ataxia Cerebelar / Doença de Machado-Joseph Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ataxia Cerebelar / Doença de Machado-Joseph Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article